These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23550609)

  • 1. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.
    Patel M; Souto EB; Singh KK
    Expert Opin Drug Deliv; 2013 Jul; 10(7):889-905. PubMed ID: 23550609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
    Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
    Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal polymeric nanoparticles and brain drug delivery.
    Khalil NM; Mainardes RM
    Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.
    Nagpal K; Singh SK; Mishra DN
    Expert Opin Drug Deliv; 2013 Jul; 10(7):927-55. PubMed ID: 23330786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
    Zhao YZ; Lu CT; Li XK; Cai J
    Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
    Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles for targeted brain drug delivery.
    Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
    Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes for brain delivery.
    Lai F; Fadda AM; Sinico C
    Expert Opin Drug Deliv; 2013 Jul; 10(7):1003-22. PubMed ID: 23373728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
    Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
    Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances on drug delivery nanocarriers for cerebral disorders.
    Zhou Z; Sun T; Jiang C
    Biomed Mater; 2021 Feb; 16(2):024104. PubMed ID: 33455956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
    Kathe N; Henriksen B; Chauhan H
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate devices for brain drug delivery.
    Celia C; Cosco D; Paolino D; Fresta M
    Med Res Rev; 2011 Sep; 31(5):716-56. PubMed ID: 20162690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale drug delivery systems and the blood-brain barrier.
    Alyautdin R; Khalin I; Nafeeza MI; Haron MH; Kuznetsov D
    Int J Nanomedicine; 2014; 9():795-811. PubMed ID: 24550672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.